What is the long-term trend for Cumberland Pharmaceuticals's net gains (losses) on investments?

Over 2 years (2021 to 2024), Cumberland Pharmaceuticals's net gains (losses) on investments has grown at a -100.0% compound annual growth rate (CAGR), from $2.19M to $0.

What does net gains (losses) on investments mean?

Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.

Cumberland Pharmaceuticals CPIX Net gains (losses) on investments

Net gains (losses) on investments at other companies

BridgeBio PharmaBBIO

-$18.28M-17.5%

RFL

Rafael Holdings, Inc.RFL

-$1.39M-46,333%

Opko HealthOPK

-$2K+77.8%

Other financials

Income statement

See full

Revenue$9.1M-22.0%

Gross profit$7.2M-30.0%

Operating income-$3.1M-342%

Net income-$3.3M-362%

EPS (diluted)-$0.22-375%

Balance sheet

See full

Cash & equivalents$11.0M-27.1%

Total debt$4.8M-7.1%

Total equity$21.6M-24.5%

Total assets$71.0M+1.5%

Cash flow

See full

Operating cash flow$387.0K-90.1%

CapEx--100%

Free cash flow$387.0K-89.9%

Valuation

See full

Market cap$97.09M+138%

Enterprise value$90.91M+207%

P/S2.3×+1.3×

Profitability

See full

Gross margin82.9%-1.4pp

Operating margin-17.2%-125pp

Net margin-17.6%-103pp

FCF margin3.3%—

Returns & leverage

See full

Return on equity-29.4%-86.3pp

Debt / equity0.2×0.0×

Current ratio1×-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnInvestments.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's net gains (losses) on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cumberland Pharmaceuticals's net gains (losses) on investments?: Cumberland Pharmaceuticals (CPIX) reported net gains (losses) on investments of -$146.08K in Q1 2026.
What is the long-term trend for Cumberland Pharmaceuticals's net gains (losses) on investments?: Over 2 years (2021 to 2024), Cumberland Pharmaceuticals's net gains (losses) on investments has grown at a -100.0% compound annual growth rate (CAGR), from $2.19M to $0.
What does net gains (losses) on investments mean?: Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.